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Summary
OBJECTIVE: The aim of this work was to gain knowledge
on the health status of pregnant women in Switzerland,
especially their attitude to and decisions about diet, use
of medication and consumption of drugs, including alcohol
and tobacco.
METHODS: Data collected by the consecutive Swiss
Health Surveys of 2007 and 2012 on sociodemographic
and lifestyle characteristics (including nutrition), type and
intake of medication, use of alcohol, tobacco and illicit
drugs of the female population were analysed. To compare
pregnant with non-pregnant women, a group of 10 times
as many non-pregnant women (reference group, n =
3090) was matched with all the participating women who
said they were pregnant at the time of the survey (preg-
nant group, n = 309). The two groups were then com-
pared.
RESULTS: The pregnant and non-pregnant participant
groups were comparable with respect to most sociode-
mographic characteristics and both showed a high aware-
ness of health-related issues. Significantly more pregnant
than non-pregnant women revealed a high nutritional
awareness, claiming to pay attention to what they ate
(78.3 vs 73.0%). Frequent consumption of milk products
and fish, and moderate consumption of meat were found
more often in the pregnant group. Use of medication was
comparable between the two groups, except that pregnant
women took pain killers less frequently than did non-preg-
nant women (30.0 vs 61.5%) and relied more often on
prescribed medication. Pregnant women were more re-
strictive in their alcohol consumption than non-pregnant
women. Nevertheless, 10.0 and 1.9% of the pregnant
women declared consumption of wine and beer, respec-
tively, in the previous 7 days. Regular smoking was less
frequent in the pregnant group than in the reference group
(11.7 vs 30.3%) and less intensive (pregnant smokers
smoked 3.6 cigarettes fewer per day). A few pregnant
women (1.9%) said they consumed marijuana; no other il-
licit drugs were mentioned.
CONCLUSIONS: In Switzerland, women of child-bearing
age revealed high general health-awareness. During preg-
nancy, a considerable proportion of the women adapted
their diet and seemed to refrain from using pain killers and
from consuming alcohol, tobacco and illicit drugs. How-
ever, since a fairly large minority of the pregnant women
mentioned drinking alcohol and/or smoking tobacco, fur-
ther preventive work is needed.
Keywords: pregnancy, nutrition, medication, drugs, be-
haviour, Switzerland, Swiss Health Survey
Introduction
Nutrition habits, use of medication and consumption of
drugs during pregnancy have lasting effects on the devel-
opment of the embryo/fetus [1]. To improve the health of
future generations, pregnant women should be aware of
these lasting effects and receive adequate support to better
deal with the new responsibility for their unborn child. Sur-
veys from various western countries show that, although
most women adapt their lifestyle during pregnancy in an
effort to improve their health status and that of their unborn
children, a considerable proportion still exhibit risky be-
haviours (for example, see [2–5]). We wanted to charac-
terise the lifestyle of pregnant women in Switzerland with
respect to nutrition habits, use of medication and consump-
tion of drugs.
In Switzerland, several organisations have engaged in
helping women to cope with the challenges posed by preg-
nancy. The (medical) Swiss Society of Gynaecology and
Obstetrics published recommendations for preconception
counselling in 2010. According to these recommendations,
women who want to get pregnant should receive informa-
tion about healthy nutrition, be encouraged to normalise
their weight, be instructed to replace possibly teratogen
medication with less hazardous alternatives, and stop using
alcohol, tobacco and illicit drugs [6]. It is, however, un-
clear what proportion of women visit preconception coun-
selling before getting pregnant. After conception, at the
first pregnancy visit to the obstetric provider, a general
anamnesis is recorded, and topics such as nutrition (includ-
ing supplementation), medications and hygiene should be
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covered. An official brochure edited by the Swiss Public
Health Office on nutritional information during pregnancy
is available, but, to our knowledge, no official brochures
about use of medication and substance abuse for pregnant
women exist. The Swiss Working Group for Perinatal
Pharmacology has been editing monographs for health care
professionals on medication during pregnancy; in 2016, it
also edited one about substance abuse during pregnancy
(monographs available at http://www.sappinfo.ch/). Be-
sides using the visits to the obstetric provider to obtain the
needed information, pregnant women can directly contact
pharmacies and midwife organisations or, in acute situa-
tions, the Swiss Teratogen Information Service and Tox In-
fo Suisse, the Swiss provider of a hotline for queries on in-
toxication.
Every five years, an extensive health survey is carried out
by the Swiss Federal Statistical Office on behalf of the
Federal Council, in order to assess the self-reported health
status of the inhabitants of Switzerland. So far, there have
been five surveys (1992, 1997, 2002, 2007 and 2012).
Their aim is to characterise the population older than 15
years and living in a private household in Switzerland [7]
with respect to perceived state of health, diseases, health
competencies and resources, use of health services, health
insurance situation, living conditions and lifestyle features
that could influence health. Typically, the surveys enable
numerous analyses (for example, see [8]). The Swiss
Health Survey has more and more come to resemble the
European Health Interview System (EHIS), in order to en-
able better international comparison. Pregnancy was nei-
ther an inclusion nor exclusion criterion, but all female par-
ticipates were asked whether they are pregnant at the time
of the survey.
The aim of this study was to describe various aspects
of health in pregnant women in Switzerland, using the
most recent data from the Swiss Health Surveys (2007 and
2012). We focused on the use of medication and drugs
(alcohol, tobacco and illicit drugs); furthermore, several
health-related behaviour and lifestyle aspects, including
nutritional habits and physical activity levels, were char-
acterised. In order to better evaluate the situation of preg-
nant women, data are shown side-by-side with those from a
matched group of non-pregnant women. The implications
of our work to improve health awareness programmes are
discussed.
Methods
Ethics statement
This study was carried out in accordance with the Helsinki
Declaration and with the Swiss laws and regulations. In
compliance with Swiss Federal Law on data protection
(Human Research Act, Article 2), the data were
anonymised and irreversibly de-identified before use in the
analysis. Therefore, the present work did not need approval
from an ethics committee.
Selection and description of participants
We wanted to use the most recent available data from the
Swiss Health Surveys on pregnant women. Preliminary
analysis of the survey from 2012 revealed that only 147
women were pregnant at the time of the interviews. To in-
crease sample size, we merged data from this survey with
the data from the immediately previous survey (2007),
which included 162 pregnant women. The present analysis
was therefore performed on 309 pregnant women. For
comparison, data from non-pregnant women matched to
the pregnant participants were include in the analysis (see
below).
The basic population of the Swiss Health Surveys 2007
and 2012 was anyone registered as living in Switzerland
and aged 15 years or older, except people living in care
homes, hospitals, boarding schools, hotels, monasteries,
prison or anyone in the process of claiming asylum. Every
registered household was therefore part of the basic pop-
ulation and could possibly be chosen to take part in the
health survey. A stratified random sampling procedure
based on registries of inhabitants was followed, with the
Swiss cantons used as strata. The net sample of each sur-
vey year were 10 000 interviews equally distributed be-
tween the cantons. The cantons were allowed to increase
their samples to representative numbers, which led to a net
sample of 18 760 telephone and 14 393 written interviews
in 2007, and 21 597 telephone and 18 357 written ques-
tionnaires in 2012.
Data collection and editing
The telephone interviews were announced a week in ad-
vance in a letter and could be via either a fixed telephone
line or a mobile phone. The health survey then began
with a telephone interview, followed by a written question-
naire sent to the participants. Those not able to respond
properly to the telephone interview, for example because
of hearing or speaking difficulties, could have a face-to-
face interview. Because of language problems (such as
not understanding German, French or Italian), age prob-
lems or mental disability, 3% of the interviews were with
a representative such as a close family member. The in-
terviews with a representative were shortened, as rather
personal questions and questions about attitude could not
be expected to be judged properly by a representative.
The questions not asked were marked “PROXY” in the
datasets. The written questionnaire could be answered on
paper or online. The majority (88%) of the participants
who were interviewed by telephone agreed to complete the
written questionnaire. The interviews were in one of the
three most widely spoken national languages – German,
French or Italian – according to the participant’s prefer-
ence. The inquiries were distributed throughout the year to
minimise seasonal influences on health status. Most top-
ics were opened with a general question followed by more
detailed questions only for the group of interest. For in-
stance, in the case of "Have you ever consumed drugs in
your life?", whoever answered “no” was filtered out, i.e.,
was not asked the more detailed questions on the same sub-
ject and the place to enter the answer was recorded as “was
not asked” in the datasets. When appropriate, participants
could answer “I don't know” or “no answer”.
Three files from each of the Swiss Health Surveys of 2007
and 2012 containing data collected by telephone interview,
a written self-administered questionnaire and calculated in-
dices were merged. To be able to merge data from the
health surveys 2007 and 2012, the text of all questions was
checked for similarity. In most cases, the text was iden-
tical. In some cases, minor differences were detected, re-
quiring small adjustments of categorical variables such as
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fusion of two categories or splitting of one category by
logical combination of information derived from two vari-
ables (not shown). The two following fusions concern dif-
ferent phrasings in the two surveys, might have slightly in-
fluenced the analysis, and therefore are shown here:
1. In 2007, the section on marijuana and ecstasy con-
sumption was introduced by the question “Do you
still consume marijuana/ecstasy?”. In 2012, the corre-
sponding question was “Have you consumed marijua-
na/ecstasy within the last twelve months?”. These two
questions have been set as equivalent in order to give
an idea of current marijuana and ecstasy consumption.
2. In 2007, participants were asked “Have you ever con-
sumed drugs other than marijuana, heroin, cocaine,
methadone or ecstasy?”, whereas in 2012 the corre-
sponding question was “Have you ever consumed oth-
er drugs (e.g. Speed, LSD, hallucinogenic mush-
rooms)?” These two questions have been considered to
be equivalent here.
Statistical analysis
Numerous variables were considered in the present analy-
sis. For reasons of space they are not listed here, but can
easily be found in the Results section. It should be noted
that the consumption of alcohol was surveyed by asking
about consumption within the last 7 days and within the
last 12 months, and about alcohol type, frequency and
amount consumed. Tobacco consumption was charac-
terised in terms of amount and type, age at beginning of
regular smoking, attempts and desire to quit and second-
hand smoke (passive smoking). The section on drug con-
sumption started with a general question about ever having
tried drugs, and continued with more questions about the
types of drugs, consumption frequency in the past and cur-
rent consumption.
Pregnancy was considered as the primary variable in the
present analysis and was used to define two groups of fe-
male participants, namely those who were pregnant and
those who were not pregnant (reference group). All out-
comes were compared between these two participant
groups. To reduce possible bias due to differences between
the two groups, propensity score matching was performed
(logit scale with a calliper of 0.2). The propensity score
calculation was based on a logistic regression model and
included the following variables: age, language area and
year of health survey. A total of 10 753 women were ten-
tatively matched to the 309 pregnant women with a ratio
of 10:1, yielding a matched reference group consisting of
3090 women.
Categorical variables are presented as numbers and corre-
sponding percentages, and data from the two groups were
compared with the chi-square test or with the Fisher’s ex-
act test, as appropriate. Continuous variables are shown as
mean, standard deviation and first and third quartiles; pos-
sible differences between the two groups were detected by
using the Mann-Whitney U-test. In all cases, two-sided p-
values smaller than 0.05 were considered statistically sig-
nificant. The number of valid answers available in each
case is shown. All statistical analyses were run using IBM
SPSS Statistics (Version 23.0. Armonk, NY: IBM Corp,
USA). Propensity score matching was done using the
package Matching [9].
Results
Sociodemographic aspects
As expected from the matching procedure, the groups of
pregnant and reference (non-pregnant) women were simi-
lar in age, language area and year of health survey (table
1). Furthermore, the two groups did not differ in housing
environment, distribution across the regions of Switzer-
land, employment status, satisfaction with their job, not be-
ing afraid of losing their job and mean net income of the
entire household. Statistically significant differences be-
tween the pregnant group and the reference group were
found for marital status, percentage of foreigners and ori-
gin of foreigners. Even though not significant (p = 0.052,
data not shown), a tendency toward a higher education
level was found in the pregnant group. Finally, pregnant
women earned CHF 106.7 more per month than their
matched non-pregnant women (p = 0.042).
Health status and health awareness
Most women reported having good or even very good
health (table 2); in this respect, no difference was found
between the two groups. Only 0.3% in the pregnant group
and 1.5% in the reference group said they had bad or very
bad health. Pregnant women less frequently reported being
affected by a long-term medical problem. The number of
women with a diagnosis of high blood pressure was similar
in the two groups: 10.0 and 8.8%. Current blood pressure,
however, was more often in the normal range in the preg-
nant group than in the reference group. For the self-report-
ed psychological stress level, pregnant women seemed to
be less stressed, as 83.2% stated they had little psycholog-
ical stress, compared with 78.0% in the reference group.
The opposite situation was observed for physical discom-
fort: pregnant women faced more physical discomfort than
the reference group. Most women had at least one person
they could talk to about personal problems; only 1.0% in
the pregnant group and 2.8% in the reference group denied
having anyone to talk to about personal problems.
Fewer women in the pregnant group than in the reference
group had a general practitioner (79.0 vs 84.6%). Accord-
ingly, pregnant women had fewer consultations with their
general practitioners: on average one consultation fewer
during the previous 12 months. On the other hand, con-
sultations with any physician (e.g., a gynaecologist) were
more often reported by the pregnant group: 5.5 times in the
pregnant group and 1.7 times in the reference group. As
expected, the reason for the most recent consultation with
the gynaecologist was pregnancy in 93.5% of the pregnant
group (data not shown). The majority of the two groups
(71.8% in the pregnant group and 65.9% in the non-preg-
nant group) had additional insurance for complementary
medicine.
The answers to a general question on whether health-re-
lated concerns affect lifestyle were comparable between
the two groups (table 3). The majority of women stated
that thoughts about health affected their lifestyle. Some
pregnant and non-pregnant women even said that thoughts
about health determined their lifestyle (17.3 and 15.1%, re-
spectively) and only a few stated that they lived without
thinking about health at all (8.8 and 10.5%, respectively).
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Attitudes towards nutrition, diet and exercise
Most women revealed high nutritional awareness, stating
that they paid attention to what they ate. This was signif-
icantly more frequent in the pregnant group (78.3%) than
in the reference group (73.0%). However, the majority of
all participants (86.4% in the pregnant group, 87.2% in
the reference group) did not follow a specific diet (see
table 3). Participants who were following a specific diet
gave the following reasons for the diet: in the pregnant
group, to lose weight (45.2%), medical reasons (28.6%)
and other reasons (26.2%); in the reference group, to lose
weight (61.3%), medical reasons (20.5%) and other rea-
Table 1: Sociodemographic characteristics of the pregnant women and matched non-pregnant women participating at the Swiss Health Surveys 2007 and 2012.
Pregnant group
(N = 309)
Non-pregnant group
(reference, N = 3090)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
p-value
Swiss Health Survey (matching variable) 0.088
2007 147 / 309 47.6 1627 / 3090 52.7
2012 162 / 309 52.4 1463 / 3090 47.3
Age in years
(matching variable)
31.7 (4.9) (28, 35) 31.9 (5.5) (28, 36) 0.54
Language area(matching variable) 0.2
Swiss German 194 / 309 62.8 2030 / 3090 65.7
French 93 / 309 30.1 910 / 3090 29.4
Italian 22 / 309 7.1 150 / 3090 4.9
Marital status <0.001*
Single 58 / 309 18.8 1362 / 3089 44.1
Married 238 / 309 77.0 1527 / 3089 49.4
Other (divorced, separated, registered partner-
ship, widowed)
13 / 309 4.2 200 / 3089 6.5
Housing area 0.33
Urban 224 / 309 72.5 2158 / 3090 69.8
Countryside 85 / 309 27.5 932 / 3090 30.2
Region of Switzerland 0.45
Lake Geneva region 55 / 309 17.8 568 / 3090 18.4
Espace Mittelland 67 / 309 21.7 713 / 3090 23.1
North-western Switzerland 45 / 309 14.6 415 / 3090 13.4
Zurich 41 / 309 13.3 353 / 3090 11.4
Eastern Switzerland 35 / 309 11.3 380 / 3090 12.3
Central Switzerland 44 / 309 14.2 514 / 3090 16.6
Ticino 22 / 309 7.1 147 / 3090 4.8
Nationality 0.001*
Swiss 213 / 309 68.9 2387 / 3089 77.3
Other 96 / 309 31.1 702/ 3089 22.7
Origin of non-Swiss 0.001*
Europe 65 / 96 67.7 588 / 702 83.8
North America 2 / 96 2.0 10 / 702 1.4
South America, incl. Caribbean 12 / 96 12.5 28 / 702 4.0
Asia 13 / 96 13.5 51 / 702 7.3
Africa 4 / 96 4.2 25 / 702 3.6
Paid work 0.001*
Yes 222 / 307 72.3 2475 / 3073 80.5
No 85 / 307 27.7 598 / 3073 19.5
Full-time or part-time 0.058
Full-time 90 / 271 33.2 1110 / 2827 39.3
Part-time 181 / 271 66.8 1717 / 2827 60.7
n = 164 n = 1809Degree of employment in percentage
61.1 (27.8) (40, 80) 65.1 (29.8) (40, 100)
0.093
Degree of employment in groups 0.001*
90–100% 92 / 269 34.2 1187 / 2807 42.3
70–89% 24 / 269 8.9 333 / 2807 11.9
50–69% 43 / 269 16.0 266 / 2807 9.5
<50% 110 / 269 40.9 1021 / 2807 36.4
n = 244 n = 1956Net income of the entire household (CHF per
month) 8235 (4402) (5800, 10 000) 8150 (5735) (5500, 9500)
0.34
n = 266 n = 2683Personal net income (CHF per month)
3168 (5470) (575, 4100) 3061 (2685) (1000, 4500)
0.042*
* Difference between the two groups statistically significant (p <0.05)
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sons (20.5%). Accordingly, pregnant women were signif-
icantly more satisfied with their own body weight than
the non-pregnant women. Whereas in the pregnant group,
34.6% of the women stated they were very satisfied and
45.1% said they were mostly satisfied, in the reference
group 27.1% were very satisfied and 40.6% mostly satis-
fied. Despite these differences, the average body mass in-
dex (BMI) in the pregnant group before pregnancy and the
present BMI in the reference group were within the normal
range and identical (22.7 kg/m2). The majority of women
had a normal weight (74.8% of the pregnant and 71.4%
of the non-pregnant). The remaining women were most-
ly overweight (15.7 and 15.0%), or underweight (5.6 and
8.1%) or strongly overweight (3.9 and 5.4%).
The number of daily fruit portions and vegetable/salad in-
take were similar in the two groups (table 3); in both cases,
a considerable proportion of the women (39.8 and 40.2%,
respectively) reported eating one or two portions of fruit
daily. Pregnant women consumed more milk products per
day than did non-pregnant women. In the pregnant group,
66.1% of women had two or more milk products per day,
compared with 50.4% in the reference group. Only 1.9% of
the pregnant women claimed to be vegetarian, whereas in
the reference group, 5.6% said they were. Moreover, 1.0%
of the pregnant women and 2.0% of the reference group ate
meat less often than once per week. In the category of eat-
ing meat once to four times per week, the corresponding
value was higher in the pregnant group (74.1 vs 63.3%).
Fish consumption seemed to be more popular in the preg-
nant group. Only 6.1% of the pregnant women reported not
eating fish at all, a result markedly lower than in the refer-
ence group (12.3%). Women eating fish less than once per
week were rarer in the pregnant group (21.0 vs 24.9% in
the reference group).
When participants were asked whether they thought they
performed enough physical activity to maintain their
health, answers were divided: 52.3% of the pregnant and
51.8% of the non-pregnant group thought they did, where-
Table 2: Health status of the pregnant women and matched non-pregnant women participating at the Swiss Health Surveys 2007 and 2012.
Pregnant group
(N = 309)
Non-pregnant group
(reference, N = 3090)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
p-value
Self-reported state of health 0.29
Very good 126 / 309 40.8 1103 / 3089 35.7
Good 164 / 309 53.1 1723 / 3089 55.8
Medium 18 / 309 5.8 216 / 3089 7.0
Bad 1 / 309 0.3 32 / 3089 1.0
Very bad 0 / 309 0.0 15 / 3089 0.5
Having a long lasting medical problem <0.001*
Yes 38 / 309 12.3 654 / 3089 21.2
No 271 / 309 87.7 2435 / 3089 78.8
High blood pressure (diagnosed by a physician) 0.47
Yes 31 / 309 10.0 271 / 3082 8.8
No 278 / 309 90.0 2811 / 3082 91.2
Current blood pressure 0.014*
Normal 237 / 288 82.3 2268 / 2874 78.9
Too high 8 / 288 2.8 34 / 2874 1.2
Too low 43 / 288 14.9 572 / 2874 19.9
Physical discomforts <0.001*
No discomfort/almost no discomforts 63 / 287 22.0 919 / 2835 32.4
Some discomforts 115 / 287 40.1 1131 / 2835 39.9
A lot of discomforts 109 / 287 37.9 785 / 2835 27.7
Psychological stress 0.047*
High 8 / 286 2.8 174 / 2953 5.9
Middle 40 / 286 14.0 476 / 2953 16.1
Low 238 / 286 83.2 2303 / 2953 78.0
Having someone to talk to about personal problems 0.093
Yes, more than 1 person 226 / 289 78.2 2364 / 2969 79.6
Yes, 1 person 60 / 289 20.8 521 / 2969 17.5
No 3 / 289 1.0 84 / 2969 2.8
Having a general practitioner 0.01*
Yes 244 / 309 79.0 2612 / 3088 84.6
No 65 / 309 21.0 476 / 3088 15.4
n = 229 n = 2206Number of consultation with the general prac-
titioner in the past 12 months 1.5 (3.1) (0, 2) 2.3 (4.6) (0, 3)
<0.001*
Consultation with any physician in the past 12 months
Yes 306 / 309 99.0 2665 / 3089 86.3
No 3 / 309 1.0 424 / 3089 13.7
<0.001*
n = 303 n = 2639Number of consultations with any physician
7.1 (5.3) (4,10) 5.0 (8) (1, 5)
<0.001*
* Difference between the two groups statistically significant (p <0.05)
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Table 3: Attitudes towards health, nutrition, own weight and diet of the pregnant women and matched non-pregnant women participating in the Swiss Health Surveys 2007 and
2012.
Pregnant group
(N = 309)
Non-pregnant group
(reference, N = 3090)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
p-value
Health concerns affect lifestyle 0.53
I live without thinking about health 22 / 249 8.8 261 / 2484 10.5
Thoughts about health affect lifestyle 184 / 249 73.9 1847 / 2484 74.4
Thoughts about health determine lifestyle 43 / 249 17.3 376 / 2484 15.1
Nutritional awareness 0.043*
Yes, I pay attention to something 242 / 309 78.3 2252 / 3086 73.0
No, I don't pay attention to anything 67 / 309 21.7 834 / 3086 27.0
Specific diet 0.7
Yes 42 / 309 13.6 396 / 3090 12.8
No 267 / 309 86.4 2694 / 3090 87.2
Reason for specific diet 0.13
To lose weight, without medical reason 19 / 42 45.2 242 / 395 61.3
Medical reasons 12 / 42 28.6 81 / 395 20.5
Other reasons 11 / 42 26.2 72 / 395 18.2
Satisfaction with body weight <0.001*
Very satisfied 99 / 286 34.6 804 / 2969 27.1
Mostly satisfied 129 / 286 45.1 1205 / 2969 40.6
Not entirely satisfied 43 / 286 15.0 693 / 2969 23.3
Not satisfied at all 15 / 286 5.2 267 / 2969 9.0
n = 305 n = 3064Body mass index (kg/m2)
22.7 (3.5) (20.2, 24.2) 22.7 (4.1) (19.9, 24.2)
0.3
Daily fruit intake (number) 0.088
0 0 / 264 0.0 6 / 2546 0.2
Never 31 / 264 11.7 433 / 2546 17.0
Fewer than 1 53 / 264 20.1 534 / 2546 21.0
1 to 2 105 / 264 39.8 1023 / 2546 40.2
3 to 4 63 / 264 23.9 463 / 2546 18.2
5 12 / 264 4.5 87 / 2546 3.4
Number of portions of vegetable/salad daily 0.53
0 0 / 268 0.0 1 / 2715 0.0
Never 24 / 268 9.0 314 / 2715 11.6
Fewer than 1 64 / 268 23.9 583 / 2715 21.5
1 to 2 132 / 268 49.3 1390 / 2715 51.2
3 to 4 37 / 268 13.8 341 / 2715 12.6
5 11 / 268 4.1 86 / 2715 3.2
Daily milk product intake (number) <0.001*
Less than 1 portion 3 / 221 1.4 34 / 1952 1.7
Approx. 1 72 / 221 32.6 935 / 1952 47.9
2 portions 104 / 221 47.1 737 / 1952 37.8
3 or more portions 36 / 221 16.3 219 / 1952 11.2
4 or more portions 6 / 221 2.7 27 / 1952 1.4
Weekly consumption of meat/sausages 0.009*
Never 6 / 309 1.9 173 / 3086 5.6
1 day per week 27 / 309 8.7 250 / 3086 8.1
2 days per week 61 / 309 19.7 454 / 3086 14.7
3 days per week 87 / 309 28.2 734 / 3086 23.8
4 days per week 54 / 309 17.5 516 / 3086 16.7
5 days per week 26 / 309 8.4 366 / 3086 11.9
6 days per week 14 / 309 4.5 138 / 3086 4.5
7 days per week 31 / 309 10.0 393 / 3086 12.7
More rarely 3 / 309 1.0 62 / 3086 2.0
Weekly consumption of fish 0.002*†
Never 19 / 309 6.1 381 / 3087 12.3
1 day per week 151 / 309 48.9 1340 / 3087 43.4
2 days per week 48 / 309 15.5 402 / 3087 13.0
3 days per week 20 / 309 6.5 126 / 3087 4.1
4 days per week 1 / 309 0.3 36 / 3087 1.2
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Pregnant group
(N = 309)
Non-pregnant group
(reference, N = 3090)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
p-value
5 days per week 3 / 309 1.0 14 / 3087 0.5
6 days per week 0 / 309 0.0 7 / 3087 0.2
7 days per week 2 / 309 0.6 11 / 3087 0.4
More rarely 65 / 309 21.0 770 / 3087 24.9
* Difference between the two groups statistically significant (p <0.05) † Fisher's Exact Test
as 47.7 and 48.2%, respectively, thought they did not (table
4). Some form of leisure exercise enough to cause sweating
once a week was reported by approximately half the preg-
nant women, which was less than in the reference group.
Pregnant (and non-pregnant) women reported doing easy
activities such that they became out of breath at some point
for 90.4 (and 93.0) minutes daily.
There was a significant difference between the groups in
the practice of fitness, sports or gymnastics. Pregnant
women did less of these sports than women in the refer-
ence group (frequency, duration, extent and intensity were
significantly lower in the pregnant group).
Medication
The consumption of medications in general within the pre-
vious 7 days was comparable between the two groups
(table 5). Thirty-nine per cent (38.8%) of the pregnant and
42.7% of the non-pregnant women had used a (convention-
al) medication. Of the 120 pregnant women who report-
ed taking medication within the previous 7 days, the type
of medication could be identified with subsequent ques-
tions in 52 cases. The results show that 36 women took
pain killers, 1 woman blood pressure medication, 2 women
sleeping pills, 3 women tranquilizers, 5 women asthma
medications, 4 women antidepressants and 1 woman di-
abetes medication. Use of the various medications was
comparable among pregnant and non-pregnant women, ex-
cept in the case of pain killers. Pregnant women took sig-
nificantly fewer pain killers compared with the reference
group (daily use 5.0 vs 11.0%; once per week to several
times per week 25 vs 50.5%). Furthermore, the majority of
the pregnant group, but only a minority of the non-preg-
nant women, used pain killers prescribed by the physician
(66.7 vs 35.2%).
The use of acupuncture, traditional Chinese medicine,
homeopathy, herbal medicine, shiatsu/foot reflexology, In-
dian medicine/Ayurveda and osteopathy within the pre-
vious 12 months was comparable in the two participant
groups and no difference was seen in the frequency of con-
sultations with an alternative practitioner (no data available
for the previous 7 days; not shown).
Table 4: Exercise performed by the pregnant women and matched non-pregnant women participating at the Swiss Health Surveys 2007 and 2012.
Pregnant group
(N = 309)
Non-pregnant group
(reference, N = 3090)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
p-value
Performs enough physical activity 0.89
Yes 150 / 287 52.3 1531 / 2954 51.8
No 137 / 287 47.7 1423 / 2954 48.2
Moving in leisure that causes sweating 1x/week
Yes 149 / 289 51.6 2065 / 2971 69.5
No 140 / 289 48.4 906 / 2971 30.5
n = 217 n = 2369
<0.001*
Moving that causes being out of breath (min/
day) 90.4 (81.2) (60, 120) 93.0 (92.2) (45, 120) 0.68
Doing fitness, sports or gymnastics <0.001*
Yes 133 / 309 43.0 1886 / 3090 61.0
No 176 / 309 57.0 1204 / 3090 39.0
Frequency of doing fitness, sports or gymnastics 0.034*
Almost daily 6 / 133 4.5 182 / 1886 9.7
Few times per week 56 / 133 42.1 930 / 1886 49.3
Approx. once per week 64 / 133 48.1 678 / 1886 35.9
Approx. 1 to 3 times per month 7 / 133 5.3 86 / 1886 4.6
Less than once per month 0 / 133 0.0 10 / 1886 0.5
n = 130 n = 1810Duration of fitness, sports or gymnastics
(minutes/week) 150.0 (127.3) (60, 180) 189.2 (169.5) (90, 240)
0.002*
Extent and intensity of weekly exercise 0.001*
Inactive 47 / 289 16.3 327 / 2959 11.1
Partly active 76 / 289 26.3 649 / 2959 21.9
Irregularly active 73 / 289 25.3 772 / 2959 26.1
Regularly active 44 / 289 15.2 404 / 2959 13.7
Trained 49 / 289 17.0 807 / 2959 27.3
* Difference between the two groups statistically significant (p <0.05)
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Alcohol and tobacco
The pregnant group was more restrictive towards alcohol
consumption than the reference group (table 6). Women
in the pregnant group had drunk significantly less beer in
terms of amount and frequency during the previous 7 days.
Wine consumption was also lower in the pregnant group,
even though 31 out of the 309 pregnant women (10.0%)
reported drinking wine within the previous 7 days. Twen-
ty-eight of the pregnant women who said they had drunk
wine in the previous 7 days (i.e., 93.3%) reported drink-
ing it once or twice during the previous week. In terms of
the amount of wine, women in the pregnant group drank
significantly less. The majority (80%) of pregnant women
who reported drinking wine in the previous 7 days drank
one glass. In contrast, regarding frequency of wine drink-
ing over the previous 12 months, the women in the preg-
nant group reported drinking wine more often than the
women in the reference group.
The prevalence of tobacco consumption was significantly
lower in the pregnant group than in the reference group
(11.7 vs 30.3%). All pregnant women who reported con-
suming tobacco did so by smoking cigarettes. In the refer-
ence group, most tobacco consuming women also smoked
cigarettes (98.4%), but 1.6% consumed tobacco in other
forms, such as cigars, cigarillos, pipes or water pipes.
Among those women who smoked cigarettes, the average
number of cigarettes smoked per day was 5.1 in the preg-
nant group and 8.7 in the reference group. The majority
of women who consumed tobacco did so on a daily basis
(66.7% of the pregnant and 69.6% of the reference group).
Of the non-smokers only, significantly more women in
the pregnant group said they had smoked regularly in the
past (36.6 vs 19.9%). In both groups, most women started
smoking at an age between 17 and 18 years (on average,
17.9 years old in the pregnant group and 17.6 years old
in the reference group). Half of the pregnant smokers had
tried to quit smoking (18/36, 50.0%). This was significant-
ly more than in the reference group, in which 29.1% (265/
912) had made efforts to quit. Of the pregnant women who
were smokers and had never tried to quit smoking, the ma-
jority (11/17, 64.7%) currently wished to quit smoking. In
comparison, 46.6% (299/641) of the women in the refer-
ence group who smoked and had never tried to quit smok-
ing stated that they wished to quit. Pregnant women were
exposed to second-hand smoke for a shorter time than the
women in the reference group (on average 24.9 and 33.0
minutes daily, p = 0.008).
Table 5: Medication intake in the previous 7 days by the pregnant women and matched non-pregnant women participating at the Swiss Health Surveys 2007 and 2012.
Pregnant group
(N = 309)
Non-pregnant group
(reference, N = 3090)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
p-value
Medication intake 0.19
Yes 120 / 309 38.8 1318 / 3087 42.7
No 189 / 309 61.2 1769 / 3087 57.3
Pain killer <0.001*
Daily 6 / 120 5.0 136 / 1234 11.0
Several times per week 10 / 120 8.3 223 / 1234 18.1
Approx. once per week 20 / 120 16.7 400 / 1234 32.4
Never 84 / 120 70.0 475 / 1234 38.5
Prescription for the pain killer <0.001*
Prescribed by a physician 24 / 36 66.7 267 / 759 35.2
Self-bought 12 / 36 33.3 492 / 759 64.8
Blood pressure medication 0.61
Yes 1 / 119 0.8 45 / 1235 3.6
No 118 / 119 99.2 1190 / 1235 96.4
No answer 1 0
Heart medication 0.78
Yes 0 / 120 0.0 15 / 1235 1.3
No 120 / 120 100 1220 / 1235 98.8
Sleeping pill 0.33
Yes 2 / 120 1.6 53 / 1235 4.3
No 118 / 120 98.3 1182 / 1235 95.7
Tranquilizer 0.25
Yes 3 / 120 2.5 93 / 1234 7.5
No 117 / 120 97.5 1141 / 1234 92.5
Asthma medication 0.52
Yes 5 / 120 4.1 43 / 1235 3.5
No 115 / 120 95.8 1192 / 1235 96.5
Antidepressants 0.27
Yes 4 / 120 3.3 104 / 1235 8.5
No 116/ 120 96.7 1131 / 1235 91.6
Diabetes medication 1.0
Yes 1 / 120 0.8 11 / 1235 0.9
No 119 / 120 99.2 1224 / 1235 99.1
* Difference between the two groups statistically significant (p <0.05)
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Table 6: Alcohol consumption and smoking by the pregnant women and matched non-pregnant women participating at the Swiss Health Surveys 2007 and 2012.
Pregnant group
(N = 309)
Non-pregnant group
(reference, N = 3090)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
Frequency n/N
or
Mean (SD)
Frequency n/N
or
Mean (SD)
p-value
Usual alcohol consumption <0.001*
Twice per day 0 / 309 0.0 6 / 3088 0.2
Once per day 2 / 309 0.6 74 / 3088 2.4
Several times per week 6 / 309 1.9 206 / 3088 6.7
1 or 2 times per week 56 / 309 18.1 1045 / 3088 33.8
1 to 3 times per month 53 / 309 17.2 699 / 3088 22.6
Less than once per month 56 / 309 18.1 464 / 3088 15.0
Never, abstinent 136 / 309 44 594 / 3088 19.2
No 110 /117 94 1402 / 2029 69.1
Frequency of beer consumption during the last 7 days 0.43
3 times per day or more 0 / 7 0.0 3 / 622 0.5
Twice per day 0 / 7 0.0 4 / 622 0.6
Once per day 1 / 7 14.3 29 / 622 4.7
Almost daily 0/7 0.0 7 / 622 1.1
3 or 4 times this week 0 / 7 0.0 77 / 622 12.4
Once or twice this week 6 / 7 85.7 502 / 622 80.7
Beer consumption during the last 12 months 0.28
Yes 65 / 110 59.1 754 / 1403 53.7
No 45 / 110 40.9 649 / 1403 46.3
Frequency of beer consumption during the last 12 months 0.035*
Weekly 8 / 60 13.3 32 / 731 4.4
2-3 times per month 10 / 60 16.7 138 / 731 18.9
Approximately once per month 17 / 60 28.3 188 / 731 25.7
Less than once per month 25 / 60 41.7 373 / 731 51.0
Wine consumption during the past 7 days <0.001*
Yes 31 / 117 26.5 1325 / 2028 65.3
No 86 / 117 73.5 703 / 2028 34.7
Frequency of wine consumption during the last 7 days 0.2
Twice per day 0 / 30 0.0 5 / 1307 0.4
Once per day 1 / 30 3.3 74 / 1307 5.7
Almost daily 1 / 30 3.3 22 / 1307 1.7
3 or 4 times this week 0 / 30 0.0 140 / 1307 10.7
Once or twice this week 28 / 30 93.3 1066 / 1307 81.6
Amount of wine consumed per occasion during the last 7 days <0.001*
5dl or more 0 / 30 0.0 36 / 1307 2.8
3 to 4 dl (3–4 glasses) 1 / 30 3.3 215 / 1307 16.4
2 dl (2 glasses) 5 / 30 16.7 554 / 1307 42.4
1 dl (1 glass) 24 / 30 80.0 502 / 1307 38.4
Wine consumption during the last 12 months <0.001*
Weekly 23 / 76 30.3 52 / 599 8.7
2–3 times per month 25 / 76 32.9 190 / 599 31.7
Approximately once per month 22 / 76 28.9 204 / 599 34.1
Less than once per month 6 / 76 7.9 153 / 599 25.5
Tobacco consumption <0.001*
Yes 36 / 309 11.7 936 / 3090 30.3
No 273 / 309 88.3 2154 / 3090 69.7
Daily tobacco consumption 0.71
Yes 24 / 36 66.7 651 / 936 69.6
No 12 / 36 33.3 285 / 936 30.4
Consumption of cigarettes 1.0
Yes 36 / 36 100 921 / 936 98.4
No 0 / 36 0.0 15 / 936 1.6
n = 35 n = 894Number of cigarettes smoked per day
5.1 (5.4) (0, 8) 8.7 (8.2) (1, 15)
0.013*
Non-smokers: have you ever smoked regularly for more than 6 months? <0.001*
Yes 100 / 273 36.6 429 / 2154 19.9
No 173 / 273 63.4 1725 / 2154 80.1
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Pregnant group
(N = 309)
Non-pregnant group
(reference, N = 3090)
Frequency n/N
or
Mean (SD)
%
or
(quartiles)
Frequency n/N
or
Mean (SD)
Frequency n/N
or
Mean (SD)
p-value
n = 131 n = 1306Age at the beginning of regular smoking
(years) 17.9 (3.4) (16, 20) 17.6 (3.3) (16, 19)
0.14
Ever tried to quit smoking 0.007*
Yes 18 / 36 50.0 265 / 912 29.1
No 18 / 36 50.0 647 / 912 70.9
Wish to quit smoking 0.14
Yes 11 / 17 64.7 299 / 641 46.6
No 6 / 17 35.3 342 / 641 53.4
n = 285 n = 2919Second-hand smoke: total minutes/day
24.9 (113.4) (0, 5) 33.0 (101.7) (0,15)
0.008*
* Difference between the two groups statistically significant (p <0.05)
Illicit drugs
No difference was found between the prevalence of any
lifetime consumption of illicit drugs in the two participant
groups (defined as “at least once”; 27.4% in the pregnant
group and 28.4% in the reference group). Most of the
women who had tried illicit drugs reported consuming
marijuana (98.8 and 98.7%, respectively). The majority
had smoked marijuana at least six times or more. The age
of first marijuana consumption was between 17 and 18
years in both groups. For current consumption of marijua-
na, pregnant women were more restrictive than non-preg-
nant women. Six of the 309 pregnant women (1.9%) said
they still consumed marijuana; in the reference group, 153
out of 3090 women (5.0%) reported current consumption.
In the subgroup of women with current marijuana con-
sumption, the frequency pattern was similar between the
two groups. In the pregnant group, 25% consumed once
or more per week, 25%, one to three times per month and
50%, less than once per month. In the reference group,
18.5% consumed it once per week or more, 21.2%, one to
three times per month and 60.3% less than once per month.
Of the subgroup of women who reported ever consuming
drugs other than marijuana in their life, 7/13 pregnant
women (53.8%) and 125/185 non-pregnant women
(67.6%) said they had tried cocaine. These proportions cor-
respond to 2.3% of the whole pregnant group (7/309) and
4.1% of the whole non-pregnant group (125/3090). Current
cocaine consumption was reported only in the reference
group, in which 16.8% of all women who had ever con-
sumed cocaine reported doing so currently (21/125). The
majority (80.0%) consumed it less than once per month.
The 21 women reporting current cocaine consumption rep-
resented 0.7% of the whole reference group (n = 3090).
Earlier ecstasy consumption was mentioned by 7/309
(2.3%) of the pregnant women and 118/3090 (3.8%) of the
reference group. None of the pregnant women consumed
ecstasy currently, whereas some of the women from the
reference group who had tried ecstasy (11.9%, 14/118) re-
ported current consumption. Relative to the whole refer-
ence group, current ecstasy consumption corresponded to
0.5% (14/3090).
No pregnant woman reported ever consuming heroin,
whereas in the reference group 18 women said they had
consumed heroin once, though none of them mentioned
doing so currently. The 2007 survey included a question on
methadone consumption, which no woman in the present
analysis answered in the affirmative; in the 2012 survey,
this question was dropped.
There was no significant difference between the two par-
ticipant groups in the consumption of other illicit drugs.
Current consumption of other drugs was denied by all
pregnant women, whereas in the reference group, 12/3090
(0.4%) women reported current consumption of other
drugs, 91.7% of them less frequently than once per month.
Discussion
Among the strengths of the present work is the novelty
of the data on several aspects of women’s health during
pregnancy in Switzerland, some of which are of a sensitive
character and are therefore difficult to access in non-
anonymous situations. Even though only a small percent-
age of the women participating in each survey was preg-
nant, a considerable number of pregnant women participat-
ed in the two combined consecutive health surveys (n =
309). This enabled us to gain new insights into several so-
ciodemographic and lifestyle factors during pregnancy, as
well as the type and intake of medication, use of alcohol,
tobacco and illicit drugs. Moreover, the comparison with
a matched group of non-pregnant women revealed several
pregnancy-specific aspects. Limitations of the analysis de-
rive from the fact that the Swiss Health Surveys were not
particularly designed to characterise the situation during
pregnancy. For instance, no information is available on
how advanced the pregnancy was. The group of pregnant
women can, however, be assumed to be heterogeneous and
include women in all pregnancy stages. Furthermore, all of
the data collected by the Swiss Health Surveys are self-re-
ported, i.e., they might have been affected by both uncon-
scious and conscious factors.
Most sociodemographic and health-related lifestyle char-
acteristics were comparable in the two groups of women.
However, foreign women – from North America, South
America (including the Caribbean), Asia, and Africa, but
not from Europe – were more represented in the pregnant
group. Although the large majority of pregnant women
did paid work (72.3%), even more non-pregnant women
were gainfully employed (80.5%). However, the majority
of the pregnant women who did paid work earned more
money per month than the women in the reference group,
even though they had a lower work load. One interpreta-
tion could be that most women in Switzerland tend to wait
to get pregnant until they are in a good financial situa-
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tion. Another explanation could be that the more worry-
free lifestyle connoted by lower income might be associat-
ed with not having children [10]. No marked difference in
education and vocational classification level between the
two groups was found, even though a pregnancy might
have a negative impact on the woman’s career. Although
it might be expected that pregnant women tend to move
to the countryside [11], no differences in domicile location
were found between the two groups.
Pregnant women faced long-lasting medical problems less
often than non-pregnant women. It seems plausible that
some of those problems might more or less directly prevent
a pregnancy, or at least have discouraged the women in
question from getting pregnant [12]. Pregnancy is a period
in which women appear to be particularly motivated to fol-
low a healthy diet, among other reasons to avoid exces-
sive gestational weight gain [13]. Pregnant women tended
to have more moderate meat consumption than the refer-
ence group, as they more rarely reported intensive meat
consumption, but also more rarely reported “never” eating
meat. A possible explanation for the latter might be that
pregnant women were more afraid of nutritional deficien-
cies associated with vegetarianism. This insecurity is, how-
ever, not supported by previous work showing that a plant-
based dietary pattern with high fibre intake and less red or
processed meat intake might even lower the risk of various
health problems [14]. As fatty acid supply is critical dur-
ing pregnancy, it is important to ensure sufficient uptake of
omega-3-fatty acids to ensure healthy brain development
of the fetus and to allow normal growth, as well as meta-
bolic and immune system development for the child [15].
Our data showing that pregnant women ate relatively high
amounts of fish (a good source omega-3-fatty acids [16])
suggest that, at least in Switzerland, there is high aware-
ness of this nutritional necessity. Pregnant women did less
fitness, sports or gymnastics than the women from the ref-
erence group, which might be because pregnant women
more easily become out of breath [17]. This decreased lev-
el of sports activity during pregnancy might be associated
with a more cautious attitude during pregnancy or else with
other discomforts (e.g., nausea, pain, fatigue).
Intake of medication in the previous 7 days did not signif-
icantly differ between the two participant groups, suggest-
ing that most medications could not be dispensed with dur-
ing pregnancy. Pain killers, however, were an exception,
with markedly lower intake within the pregnant group, al-
though pregnant women tended to have more physical dis-
comfort (possibly pain, but also nausea and other common
discomforts [18]) than the women in the reference group.
The restricted intake of pain killers by pregnant women
may be due to general efforts to minimise exposure of the
fetus to medications, as they may pose a risk to the un-
born child [19, 20]. Interestingly, pregnant women who
consumed pain killers did so exclusively upon medical pre-
scription, whereas women in the reference group most-
ly bought the medication themselves. This indicates that
women more consistently relied on physicians’ advice dur-
ing pregnancy and suggests that the accompanying physi-
cians are in a privileged position to council pregnant
women.
Numerous studies have shown that alcohol consumption
during pregnancy is detrimental for the unborn child.
These studies has been recently evaluated in a meta-analy-
sis [21], whose authors conclude that, whereas prenatal
binge drinking detrimentally impacts on child cognition,
even drinking less than daily might be detrimentally as-
sociated with child behaviour. In other words, there is no
safe amount of alcohol to consume while pregnant. In line
with the general recommendations to avoid all kinds of
alcohol during pregnancy, alcohol consumption was less
common in the pregnant group. Nevertheless, about 10%
of the pregnant women reported drinking wine in the pre-
vious 7 days. Our data suggest that one to two glasses
of wine are relatively often considered not to put the un-
born child at risk [22]. Although the effects of alcohol on
the fetus are dependent on the amount ingested, the tox-
ic margins are not well delimitated [23]. Therefore, preg-
nant women might be lulled into a false sense of security,
thinking that a glass of wine cannot be so damaging. The
frequency and amount of wine consumption suggests that
most women did not drink wine because of alcohol depen-
dence, since in this case, frequency and amount would be
expected to be higher [24]. However, the accuracy of self-
reported data concerning alcohol consumption remains un-
clear [25–28]. Therefore it is very possible that the amount
of alcohol drunk during pregnancy was higher than shown
in this work. The frequency of wine drinking within the
previous 12 months was higher in the pregnant group. The
reasons for this greater consumption are unclear, but might
be related to the higher salary in this group. For instance,
in Germany, alcohol consumption in the upper classes is
markedly higher than in the low classes [3]. Even if a
direct comparison of the data is difficult (different ques-
tions and time periods), the prevalence of alcohol con-
sumption that we observed now in Switzerland appears to
be in the same range as the average value reported by a
survey in Germany. In Switzerland, 14% of the mothers
consumed (mostly occasionally) alcohol during pregnancy
(in our analysis, 10% drunk wine during the last 7 days).
This German survey also revealed that participants with-
out a migration background consumed three times more al-
cohol than participants with a migration background. This
cultural aspect should be taken into account when planning
health awareness campaigns.
Cigarette smoking has a strong impact on pregnancy and
the neonate, being considered to be the most important
modifiable risk factor associated with adverse pregnancy
outcomes [29]. Accordingly, prevalence of tobacco con-
sumption was markedly (three times) lower in the pregnant
group than in the reference group. Since more women in
the pregnant group reported having smoked regularly in
the past, these data imply that a considerable percentage
of women do have success in quitting smoking upon be-
coming pregnant or shortly before. Even though this is
per se a very positive observation from the public health
point of view, the data reveal as well that more than every
tenth pregnant woman in Switzerland does smoke during
pregnancy. This means that more prevention measures are
required. In Germany, an even higher percentage of the
mothers smoked during pregnancy (17–18% in Germany
vs 11.7% in the present analysis), with women from lower
social classes smoking four times more that participants of
the higher social classes. In the USA, comparable data on
general tobacco use were obtained; an analysis of data on
pregnant women from 2005–2014 revealed a 13.3% preva-
lence [2].
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Illicit drug consumption within the pregnant group was
limited to the use of marijuana. Although investigation of
the effects of marijuana on pregnancy outcomes is com-
plex due to confounders such as tobacco smoking, other
drug exposures and sociodemographic factors, associations
between consumption and increased neonatal morbidity
[30] or adverse birth outcomes [31] have been observed. In
our analysis, the majority of the pregnant women reporting
marijuana use did so less than once per week, suggesting
that in this case also consumption was mostly just for oc-
casional pleasure, without a typical addiction. In our opin-
ion, this raises again the question of why consumption con-
tinues during pregnancy. Since the data were self-reported
and participants might have understated their consumption,
it is conceivable that real consumption might have been
more frequent and therefore indicative of addictive behav-
iour. In the USA, comparable data on marijuana use were
obtained; an analysis from 2005–2014 revealed that 1% of
the pregnant women used marijuana (compared with 1.9%
in the present analysis) [2].
Taken together, our data on use of alcohol, smoking and
marijuana show that a considerable proportion of the preg-
nant women in Switzerland do not comply with the exist-
ing Swiss recommendations for stopping their use (see In-
troduction). Since our surveys reflect data from 2007–2012
and most of these recommendations are relatively recent, it
is conceivable that their effect was not then apparent. See-
ing the high health-awareness of the general female pop-
ulation, however, one should consider investigating (pos-
sibly with qualitative research methods) why women who
are informed about the negative effects of use of alcohol,
smoking and marijuana consumption during pregnancy are
still not stopping their use. The data from Germany, reveal-
ing that upper social classes and participants without a mi-
gration background exhibit higher alcohol use, but lower
social classes smoke more, suggest that a very differentiat-
ed approach is needed.
Conclusions
Our data indicate that during pregnancy most women try
to improve their food intake, refrain from taking (non-pre-
scribed) pain killers, and reduce their consumption of alco-
hol, cigarettes and drugs. All these changes attest to a high
awareness of the new responsibilities that pregnant women
take on and are likely to favourably affect health-related
outcomes for their unborn children. From a public health
point of view, the question that should be posed now is
whether the observed prevalence of alcohol, cigarette and
drug consumption can be still further reduced and, if so,
what measures can be suggested to achieve a reduction.
The initiative of the Swiss Society of Gynaecology and
Obstetrics to include recommendations with view to im-
proving mothers’ health by preconception counselling (i.e.,
before pregnancy) appears promising. However, it is nec-
essary that these recommendations reach all women of re-
productive age, and so they should be propagated in other
environments, such as at schools or during regular gynae-
cological check-ups. Finally, given the high health-related
awareness in the general female population of child-bear-
ing age in Switzerland, further investigations are needed to
design specific support measures.
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